Ten Simple Rules To Commercialize Scientific Research

  • Anthony C. Fletcher,

    Affiliation: Salix Management Consultants Ltd, London, England

  • Philip E. Bourne mail

    Affiliations: Department of Pharmacology, University of California San Diego, La Jolla, California, United States of America, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America

  • Published: September 27, 2012
  • DOI: 10.1371/journal.pcbi.1002712
  • Featured in PLOS Collections

Reader Comments (1)

Post a new comment on this article

Unexpected 10 Simple Rules

Posted by jpeccoud on 19 Nov 2012 at 21:52 GMT

This 10 Simple Rules article was somewhat unexpected in PLoS Computational Biology considering that the journal has a very specific policy with respect to the IP status of the software related to the material published in its columns. The journal editorial policy that requires open source release of software makes it very difficult to publish many papers related to work that may result in a non-open IP position.

I wished the article had discussed all these simple rules in the context of open source, which is the framework the journal more or less imposes on its authors. Issues like software patenting and open sources, open source and trademark registration, or even open source and copyright deserve a discussion. It would be interesting to discuss these issues from a legal and business perspectives.

No competing interests declared.